Swiss biotech company Planetary SA could be on the verge of producing its mycoprotein for less than USD $1 per kilogram ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
Protein degradation biotech EpiBiologics has brought in $107 million in a star-studded series B round headed up by Johnson & Johnson's and Google's respective venture arms. A key goal of the San ...
Taiwanese biotech HanchorBio (TPEx: 7827) has signed a strategic collaboration with WuXi Biologics (HKEX: 2269) to develop ...
Tsingke Biotech's booth at the PEGS Summit attracted attention from global biopharma professionals, with many visitors engaging in discussions and companies exploring potential collaborations. This ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
What’s new in biotech and pharma? Over the last couple of weeks, we’ve seen the unveiling of a spatial assay for visualizing functional protein–protein interactions, an energy dispersive X-ray ...
Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...
First commercially available products using AMSilk’s biotech silk protein yarnsDemonstrating a scalable, low impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results